UBS Lifts PT on HEALTHSOUTH (HLS) to $29.50
Tweet Send to a FriendGet Alerts HLS Hot Sheet
Price: $29.18 -1.82%
Rating Summary:
8 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
8 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade HLS Now!
UBS raised its price target on Buy-rated HEALTHSOUTH (NYSE: HLS) from $27 to $29.50 following strong Q4 results and aggressive share buyback.
The firm notes: "HLS's 4Q12 revs increased 6.7% Y/Y to $552.9 mln, $9.3/$7.4 mln ahead of UBSe/cons. 4Q12 adj. EBITDA increased 4.6% to $128.6 mln, $10.9 mln ahead of both UBSe/cons and signific antly better than its implied 4Q guidance of $117.7-$120.7 mln. 4Q12 adj EPS of $0.44 was $0.12 ahead of both UBSe/cons"
HEALTHSOUTH also announced it plans to tender for as much as $350 million of its common stock, which the firm views as a "a significant positive, given the company’s historic aversion to share repurchase."
The firm raised FY12 EPS form $1.50 to $1.54 and FY13 was trimmed from $1.63 to $1.62.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $22.47 yesterday, with a 52 week range of $18.44-$24.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm notes: "HLS's 4Q12 revs increased 6.7% Y/Y to $552.9 mln, $9.3/$7.4 mln ahead of UBSe/cons. 4Q12 adj. EBITDA increased 4.6% to $128.6 mln, $10.9 mln ahead of both UBSe/cons and signific antly better than its implied 4Q guidance of $117.7-$120.7 mln. 4Q12 adj EPS of $0.44 was $0.12 ahead of both UBSe/cons"
HEALTHSOUTH also announced it plans to tender for as much as $350 million of its common stock, which the firm views as a "a significant positive, given the company’s historic aversion to share repurchase."
The firm raised FY12 EPS form $1.50 to $1.54 and FY13 was trimmed from $1.63 to $1.62.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $22.47 yesterday, with a 52 week range of $18.44-$24.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS, Stock Buyback
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
